![Shao Lee Lin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shao Lee Lin
Vorstandsvorsitzender bei
CUE BIOPHARMA, INC.
Vermögen: 21 Mio $ am 30.06.2026
Profil
Shao Lee Lin was the founder of ACELYRIN, Inc., founded in 2020, serving as Chief Executive Officer & Director from 2020 to 2024.
Current jobs include President, CEO, CFO & Director at Cue Biopharma, Inc. since 2026, and Director at Surrozen Operating, Inc. since 2021.
Former jobs include Director at Principia Biopharma, Inc. from 2019 to 2020; Independent Director at Surrozen, Inc. from 2021 to 2026; Independent Director at Third Harmonic Bio, Inc. from 2020 to 2023; VP-Inflammation & Respiratory Development at Gilead Sciences, Inc. from 2012 to 2015; VP-Therapeutic Areas & Development Excellence at AbbVie, Inc. from 2015 to 2017; Chief Scientific Officer, EVP, Head-R&D at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020; and Trustee at Lake Forest College from 2018 to 2020.
Education includes undergraduate studies at William Marsh Rice University and a doctorate from The Johns Hopkins University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUE BIOPHARMA, INC. 15.6% | 09.07.2026 | 655’074 ( 15.6% ) | 21 Mio $ | 30.06.2026 |
SURROZEN INC 0.02% | 14.05.2025 | 2’341 ( 0.02% ) | 60 749 $ | 30.06.2026 |
Aktive Positionen von Shao Lee Lin
| Unternehmen | Position | Beginn |
|---|---|---|
| CUE BIOPHARMA, INC. | Vorstandsvorsitzender | 30.04.2026 |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Direktor/Vorstandsmitglied | 02.02.2021 |
Ehemalige bekannte Positionen von Shao Lee Lin
| Unternehmen | Position | Ende |
|---|---|---|
| SURROZEN, INC. | Direktor/Vorstandsmitglied | 26.01.2026 |
| ACELYRIN, INC. | Gründer | 08.05.2024 |
| THIRD HARMONIC BIO, INC. | Direktor/Vorstandsmitglied | 17.01.2023 |
| PRINCIPIA BIOPHARMA INC. | Direktor/Vorstandsmitglied | 28.09.2020 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 23.01.2020 |
Ausbildung von Shao Lee Lin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
41
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
AbbVie, Inc.
 AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Rice University
 Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lake Forest College
 Lake Forest College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Surrozen Operating, Inc.
Surrozen Operating, Inc. BiotechnologyHealth Technology Discovers and develops novel regenerative medicines | Health Technology |
Third Harmonic Bio, Inc.
 Third Harmonic Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of allergic and immune diseases and disorders | Health Technology |
ACELYRIN, Inc.
 ACELYRIN, Inc. Pharmaceuticals: MajorHealth Technology Operates as late-stage clinical biopharmaceutical company which focuses on identifying, acquiring and accelerating the development & commercialization of medicines | Health Technology |
Surrozen, Inc.
 Surrozen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing drug candidates | Health Technology |
Wählen Sie MarketScreener 
